212 related articles for article (PubMed ID: 35531683)
1. [Clinical trials and evaluation of Chinese patent medicine for chronic obstructive pulmonary disease].
Feng CN; Hu HY; Ji ZC; Qiang XY; Chen Z; Ou Y; Cao LJ; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2351-2357. PubMed ID: 35531683
[TBL] [Abstract][Full Text] [Related]
2. [Clinical trials and evaluation of Chinese patent medicine for influenza].
Sheng XD; Chen Z; Ji ZC; Hu HY; Ou Y; Cao LJ; Guo LP; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2338-2342. PubMed ID: 35531681
[TBL] [Abstract][Full Text] [Related]
3. [Clinical trials and evaluation of Chinese patent medicine for pneumonia].
Ji ZC; Qiang XY; Hu HY; Chen Z; Ou Y; Feng CN; Cao LJ; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2343-2350. PubMed ID: 35531682
[TBL] [Abstract][Full Text] [Related]
4. [Clinical trials and evaluation of Chinese patent medicine for stroke].
Feng CN; Ji ZC; Peng DH; Hu HY; Zhang JH; Pang B
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2330-2337. PubMed ID: 35531680
[TBL] [Abstract][Full Text] [Related]
5. [Clinical trials and evaluation of Chinese patent medicine for heart failure].
Wu XL; Qiang XY; Ji ZC; Hu HY; Feng CN; Wang DL; Peng DH; Cao LJ; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2322-2329. PubMed ID: 35531679
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evidence analysis report of Chinese patent medicine in 2020].
Peng DH; Qiang XY; Hu HY; Ji ZC; Feng CN; Wang DL; Wu XL; Zhang JH; Pang B
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2315-2321. PubMed ID: 35531678
[TBL] [Abstract][Full Text] [Related]
7. [Summary and evaluation of randomized controlled trial on Chinese patent medicine in treatment of diabetic foot ulcer].
Song WT; Zhang YZ; Wang YT; Hu HY; Jin XY; Pang WT; Shi ML; Ji ZC; Yang FW
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1113-1121. PubMed ID: 38621918
[TBL] [Abstract][Full Text] [Related]
8. [Evidence map of clinical research on Chinese patent medicines for post-acute myocardial infarction heart failure].
Zhang CD; Huang JY; Wang YX; Zhu MJ; Xing ZY; Qiu BY
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1673-1682. PubMed ID: 38621951
[TBL] [Abstract][Full Text] [Related]
9. [Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes].
Ma LX; Wang YY; Li XX; Liu JP
Zhong Xi Yi Jie He Xue Bao; 2012 Mar; 10(3):279-92. PubMed ID: 22409917
[TBL] [Abstract][Full Text] [Related]
10. [Guidelines for post-marketing research on clinical effectiveness of Chinese patent medicines].
Wang ZF; Xie YM; Tang JY; Zhang JH; Sun X; Yang ZQ
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):842-848. PubMed ID: 38621888
[TBL] [Abstract][Full Text] [Related]
11. [Network Meta-analysis of oral Chinese patent medicines in treatment of acute exacerbation of chronic obstructive pulmonary disease].
Ding MY; Yang SG; Yu NX; Hong YZ; Ye ZC; Yu XQ
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3373-3385. PubMed ID: 37382020
[TBL] [Abstract][Full Text] [Related]
12. [Network Meta-analysis of oral Chinese patent medicine in adjuvant treatment of rotavirus gastroenteritis in children].
Yu BY; Yang J; Xu JX; Lyu X; Wang YM; Dai XY; Gao R
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3934-3948. PubMed ID: 37475085
[TBL] [Abstract][Full Text] [Related]
13. [Evidence mapping of clinical research on 20 Chinese patent medicines for hypertension].
Wang YF; Guo LJ; Gao F; Zhang ZB; Ren GC; Ma XC
Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(18):5097-5105. PubMed ID: 36164920
[TBL] [Abstract][Full Text] [Related]
14. [Evidence map analysis of randomized controlled trial of commonly used Chinese patent medicines in treatment of type 2 diabetes mellitus in recent five years].
Jiang JJ; Jing YY; Li YY; Yang YN; Liao X; Xie YM
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1102-1112. PubMed ID: 38621917
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of traditional Chinese medicine on stable chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Haifeng W; Hailong Z; Jiansheng L; Xueqing Y; Suyun L; Bin L; Yang X; Yunping B
Complement Ther Med; 2015 Aug; 23(4):603-11. PubMed ID: 26275654
[TBL] [Abstract][Full Text] [Related]
16. Effect of Jianpi therapy in treatment of chronic obstructive pulmonary disease: a systematic review.
Gao Z; Liu Y; Zhang J; Upur H
J Tradit Chin Med; 2013 Feb; 33(1):1-8. PubMed ID: 23596804
[TBL] [Abstract][Full Text] [Related]
17. Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review.
Hu J; Qiu R; Li C; Li M; Dai Q; Chen S; Zhao C; Shang H
BMC Complement Med Ther; 2021 Aug; 21(1):217. PubMed ID: 34465313
[TBL] [Abstract][Full Text] [Related]
18. [Network Meta-analysis of oral blood-activating and stasis-removing Chinese patent medicines in treatment of hypertensive left ventricular hypertrophy].
Zheng YW; Li J; Yao WQ; Pan MY; Fang Y
Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(5):1383-1391. PubMed ID: 35343167
[TBL] [Abstract][Full Text] [Related]
19. [Network Meta-analysis of Qi-supplementing and Yin-nourishing Chinese patent medicines in treatment of early diabetic nephropathy].
Wang WR; Zhang XM; Li JX; Yang JY; Yu RH; Xie YM
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3949-3964. PubMed ID: 37475086
[TBL] [Abstract][Full Text] [Related]
20. [Network Meta-analysis of randomized controlled trials of Chinese patent medicine for bradyarrhythmia].
Hu HY; Ji ZC; Yu DD; Yang FW; Wang H; Zheng WK; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1149-1158. PubMed ID: 32237459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
